Private Grantmaking Foundations
Jeff Gordon Childrens Foundation
CHARLOTTE, NC
Total revenue
$3.0M
Total expenses
$2.4M
Net assets
$1.9M
Grants received
$99K
25 grants
EIN
562174163
Tax year
2024
Mission
The organization's primary mission is to support children battling cancer by funding programs that improve patients' quality of life, treatment programs that increase survivorship, and pediatric medical research dedicated to finding a cure.
Programs
5 programs
V Foundation - The All-Star Grant is an ongoing support of previous V Scholar or Translational grant recipients. The V Foundation looks for the most innovative ideas to improve the cancer landscape for patients.
Cincinnati Childrens Hospital Medical Center: This grant is to fund their research project entitled Novel Treatment for Relapsed/Recurrent High-Risk B-ALL.
NMDP Foundation: This grant is to fund a portion of the research project entitled CD33CART: A Clinical Trial Providing Hope for Children and Young Adults with Relapsed/Refractory AML.
PTCTC This grant will continue support of The PTCTC Jeff Gordon Childrens Foundation New Investigator Award for encouraging clinical and/or laboratory research by young investigators in the field of pediatric transplantation and cellular therapies.
University of Texas Health Science Center at San Antonio: This grant is to support UTHSAs research project entitled Dual Targeting of Ewing Sarcoma.
Financials
FY 2024
Revenue
Expenses
People
8 listed
Susan Robinson
Executive Dir.
$175K
40 hrs/wk
Ryan Hutcheson
CFO
$27K
4 hrs/wk
Jeffery M Gordon
Founder
—
0.5 hrs/wk
David Jacobsohn MD ScM MBA
Director
—
1 hrs/wk
Jeffrey W Chell MD
Chair
—
1 hrs/wk
Javier Oesterheld MD
Director
—
1 hrs/wk
Jo Cowan
Director
—
1 hrs/wk
Jim Reichard
Director
—
1 hrs/wk
Grants received
Showing 25 of 25
Funded by
$99K from 11 funders · 25 grants · 2018–2024
$32K · 3 grants · 2022–2024
$25K · 1 grant · 2020
$22K · 2 grants · 2021–2023
$14K · 1 grant · 2023
$3K · 2 grants · 2023–2024
$1K · 3 grants · 2023–2024
$1K · 1 grant · 2020
$717 · 4 grants · 2021–2024